Literature DB >> 19724080

Structural model of the Plasmodium falciparum thioredoxin reductase:a novel target for antimalarial drugs.

Amit Kumar Banerjee1, Neelima Arora, U S N Murty.   

Abstract

BACKGROUND: Malaria, a scourge of mankind, imposes a huge socioeconomic burden in tropical countries. Emergence of multi-drug resistant malarial parasites impels us to explore novel drug targets. Thioredoxin reductase is a promising antimalarial drug target.
METHODS: The Thioredoxin reductase enzyme of Plasmodium falciparum was characterized in silico and protein disorder was predicted using available online tools. Since the crystal structure of Thioredoxin reductase of P. falciparum is not yet available, its three-dimensional structure was constructed by homology modeling using the high-resolution Thioredoxin reductase type 2 of mouse as a template. Obtained model was further refined by Molecular Dynamics (MD).
RESULTS: The model was stable during the simulation with the equilibrium root mean square deviation (RMSD) value of 1.2 A. Stereochemical evaluation revealed that 99.1% residues of the constructed model lie in the most favoured and allowed regions, thus, indicating a good quality model.
CONCLUSION: Results of this study will provide an insight into the structure of the Thioredoxin reductase of malarial parasite and aid in rational drug designing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19724080

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  2 in total

1.  Analyzing a Potential Drug Target N-Myristoyltransferase of Plasmodium falciparum Through In Silico Approaches.

Authors:  Amit Kumar Banerjee; Neelima Arora; Usn Murty
Journal:  J Glob Infect Dis       Date:  2012-01

2.  A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.

Authors:  Gregg W Snider; Christopher M Dustin; Erik L Ruggles; Robert J Hondal
Journal:  Biochemistry       Date:  2014-01-17       Impact factor: 3.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.